Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

• Elizabeth A. Guancial ,

  * E-mail: elizabeth_guancial@urmc.rochester.edu

  Affiliation Department of Medicine/James P. Wilmot Cancer Institute, University of Rochester, Rochester, New York, United States of America

  ⨯
• Deepak Kilari,

  Affiliation Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America

  ⨯
• Guang-Qian Xiao,

  Affiliation Department of Pathology, University of Rochester, Rochester, New York, United States of America

  ⨯
• Sohaib H. Abu-Farsakh,

  Affiliation Department of Pathology, University of Rochester, Rochester, New York, United States of America

  ⨯
• Andrea Baran,

  Affiliation Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, United States of America

  ⨯
• Edward M. Messing,

  Affiliation Department of Urology, University of Rochester, Rochester, New York, United States of America

  ⨯
• Eric S. Kim

  Affiliation Department of Medicine/James P. Wilmot Cancer Institute, University of Rochester, Rochester, New York, United States of America

  ⨯